Perrigo (PRGO) to Release Quarterly Earnings on Wednesday

Perrigo (NYSE:PRGO - Get Free Report) is projected to issue its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 7th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $1.09 billion for the quarter.

Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, topping analysts' consensus estimates of $0.92 by $0.01. The firm had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.20 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. On average, analysts expect Perrigo to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Perrigo Stock Performance

Shares of Perrigo stock traded down $0.61 during midday trading on Monday, hitting $25.02. The company had a trading volume of 532,124 shares, compared to its average volume of 1,519,100. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. Perrigo has a 12-month low of $23.14 and a 12-month high of $33.46. The stock has a market cap of $3.41 billion, a price-to-earnings ratio of -21.39 and a beta of 0.45. The company has a fifty day simple moving average of $26.56 and a 200 day simple moving average of $26.11.

Perrigo Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be given a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 4.64%. The ex-dividend date of this dividend is Friday, May 30th. Perrigo's payout ratio is -92.80%.

Insider Activity

In related news, EVP Ronald Craig Janish sold 7,800 shares of the company's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares of the company's stock, valued at approximately $923,795.04. This represents a 18.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently commented on PRGO. Argus downgraded Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. StockNews.com downgraded shares of Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Finally, Piper Sandler lowered shares of Perrigo from an "overweight" rating to a "neutral" rating and cut their price objective for the stock from $34.00 to $27.00 in a research note on Monday, January 6th. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $33.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.